Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.
This article is from
The Cancer Letter
archive.
Vol. 26 No. 35 | September 29, 2000
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Breast Cancer Overview Report Competed
August 5, 1988
TCL Archive
WETA Relents Will Air Documentary
April 10, 1987
TCL Archive
Chronobiology Review Still Delayed
May 5, 1989
TCL Archive
H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.
May 4, 2001
TCL Archive
Two Doses of the Vaccine Cervarix Can Be As Effective As Three
September 30, 2011
TCL Archive
Genomic Health Presents Meta-Analyses of Oncotype DX
January 28, 2011